comparemela.com

Latest Breaking News On - Prnewswire biosion united states inc - Page 1 : comparemela.com

Biosion Announces FDA Clearance of IND Application for BSI-082, a Novel Anti-SIRPα Monoclonal Antibody

/PRNewswire/ Biosion USA, Inc. (Biosion), a global clinical-stage R&D biotechnology company, today announced that the U.S. Food and Drug Administration.

Hughm davisMingjiu chenBusiness developmentBiosion united states incPrnewswire biosion united states incDrug administrationBiosion incUnited statesInvestigational new drugChief executive officerAntibody drug conjugatesChief businessDevelopment officerBiosion united statesHealth care amp hospitalsClinical trials amp medical discoveries

Biosion Announces Phase II Study Start for Anti-TSLP mAb BSI-045B in Atopic Dermatitis (ADAMANT)

/PRNewswire/ Biosion USA, Inc. (Biosion), a global clinical-stage R&D biotechnology company, today announced the phase 2 study initiation for the evaluation.

Hughm davisPrnewswire biosion united states incBiosion incUnited statesDevelopment officerBiosion united

Biosion Initiates Phase II Clinical Trial of BSI-045B in Atopic Dermatitis

/PRNewswire/ Biosion USA, Inc. (Biosion), a global clinical-stage R&D biotechnology company, today announced that it has successfully opened an IND.

Hugh davisPrnewswire biosion united states incDrug administrationBiosion incUnited statesChief operating officerBiosion united

Biosion Announces Research Collaboration with ImmunoGen to Create Novel Antibody-Drug Conjugates

/PRNewswire/ Biosion USA, Inc. (Biosion), a global R&D biotechnology company, today announced an exploratory research collaboration to create antibody-drug.

Hugh davisEwen bazirakeBiosion syntracerBiosion incPrnewswire biosion united states incImmunogen incBusiness developmentBiosion united states incUnited statesChief operating officerBiosion united statesHigh throughput

vimarsana © 2020. All Rights Reserved.